Vanguard Global Advisers’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$875K Buy
202,956
+44,259
+28% +$198K ﹤0.01% 1803
2026
Q2
$832K Sell
158,697
-597
-0.4% -$2.03K ﹤0.01% 1849
2026
Q1
$280K Hold
159,294
– – ﹤0.01% 2276

Other funds holding CLOV

Vanguard Global Advisers's CLOV Position: Q3 2026 in Review

Vanguard Global Advisers increased its Clover Health Investments (CLOV) stake by 28% in Q3 2026, buying an estimated $198K and bringing the position to 202,956 shares worth $875K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Vanguard Global Advisers first reported a position in CLOV in Q1 2026 and has held it in 3 quarters since. 230 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

  • Vanguard Global Advisers held 202,956 shares of Clover Health Investments worth $875K as of Q3 2026.
  • Vanguard Global Advisers bought 44,259 Clover Health Investments shares in Q3 2026, an estimated $198K.
  • Clover Health Investments made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1803 holding.
  • Vanguard Global Advisers first reported a position in Clover Health Investments in Q1 2026 and has held it in 3 quarters since.
  • 230 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.